NF‑κB, inflammation, immunity and cancer: coming of age Abstract | Fourteen years have passed since nuclear factor‑κB (NF‑κB) was first shown to serve as a molecular lynchpin that links persistent infections and chronic inflammation to increased cancer risk. The young field of inflammation and cancer has now come of age, and inflammation has been recognized...
